Among patients presenting for vaginitis evaluation, bacterial vaginosis was found to be strongly associated with increased risk of nonviral sexually transmitted coinfection, as published in O&G Open. Researchers retrospectively studied 1.5 million women who received molecular testing for bacterial vaginosis, vulvovaginal candidiasis, and sexually transmitted infection (STI) from 2022–2024 in the United States. They found bacterial vaginosis was detected in 38.7% of patients and vulvovaginal candidiasis was detected in 28.5% of patients—with 10.8% of patients …
Read More